Department of Neurology, Neuroscience Center, The First Hospital of Jilin University, Jilin University, 71 Xinmin Street, Chaoyang District, Changchun, China.
Neurocrit Care. 2022 Aug;37(1):121-128. doi: 10.1007/s12028-022-01457-8. Epub 2022 Mar 25.
Respiratory support is required in 20-30% of patients with Guillain-Barré syndrome (GBS). We investigated clinical and biological risk factors for mechanical ventilation (MV) in northeast China through a retrospective GBS study. The Erasmus GBS Respiratory Insufficiency Score (EGRIS) is a prognostic model for MV in patients with GBS, and its usefulness has been validated in several countries but not in China. Therefore, we intended to validate the EGRIS model in our GBS cohort.
A total of 252 patients with GBS were included in this study from January 2013 to October 2017. Risk factors for MV were identified via multivariate logistic regression analysis. The prognostic value of the EGRIS was validated via receiver operating characteristic curve analysis.
Thirty-one patients (12.3%) required MV (mean age 54.19 years), with a majority being male (77.4%). The risk factors for MV were male sex [odds ratio (OR) 3.720, 95% confidence interval (CI) 1.155-11.985, p < 0.05], shorter interval from onset to admission (OR 0.830, 95% CI 0.711-0.970, p < 0.05), lower Medical Research Council sum score at admission (OR 0.942, 95% CI 0.911-0.973, p < 0.001), neutrophil-to-lymphocyte ratio at admission (OR 1.174, 95% CI 1.049-1.315, p < 0.01), and cranial nerve deficit (OR 3.805, 95% CI 1.373-10.541, p < 0.05). The EGRIS had a good predictive ability for MV (area under the receiver operating curve 0.861) in patients with GBS, and a high EGRIS was a predictor for MV (OR 8.778, 95% CI 3.432-22.448, p < 0.001). However, there was no significant difference in ganglioside administration between ventilated and nonventilated patients.
An elevated neutrophil-to-lymphocyte ratio at admission and a high EGRIS could serve as predictors for MV in our GBS cohort.
吉兰-巴雷综合征(GBS)患者中有 20-30%需要呼吸支持。我们通过回顾性 GBS 研究调查了中国东北地区机械通气(MV)的临床和生物学危险因素。Erasmus GBS 呼吸衰竭评分(EGRIS)是一种预测 GBS 患者 MV 的预后模型,其在多个国家得到了验证,但在中国尚未得到验证。因此,我们打算在 GBS 队列中验证 EGRIS 模型。
本研究纳入了 2013 年 1 月至 2017 年 10 月期间的 252 例 GBS 患者。通过多变量逻辑回归分析确定 MV 的危险因素。通过接收者操作特征曲线分析验证 EGRIS 的预后价值。
31 例(12.3%)患者需要 MV(平均年龄 54.19 岁),其中大多数为男性(77.4%)。MV 的危险因素包括男性(比值比 [OR] 3.720,95%置信区间 [CI] 1.155-11.985,p<0.05)、发病至入院时间较短(OR 0.830,95%CI 0.711-0.970,p<0.05)、入院时的改良医学研究理事会评分较低(OR 0.942,95%CI 0.911-0.973,p<0.001)、入院时的中性粒细胞与淋巴细胞比值较高(OR 1.174,95%CI 1.049-1.315,p<0.01)和颅神经缺损(OR 3.805,95%CI 1.373-10.541,p<0.05)。EGRIS 对 GBS 患者 MV 具有良好的预测能力(受试者工作特征曲线下面积为 0.861),高 EGRIS 是 MV 的预测因子(OR 8.778,95%CI 3.432-22.448,p<0.001)。然而,通气和非通气患者之间神经节苷脂的给药没有显著差异。
入院时较高的中性粒细胞与淋巴细胞比值和较高的 EGRIS 可作为我们 GBS 队列中 MV 的预测因子。